Azelaic acid 15% gel
Customize your policy alerts
Sign up for Oscar Health Policy PG059 alerts
Get alerted when Policy PG059 changes without checking for updates manually.
Monitor payer policy activity
This guideline governs prior authorization and medical-necessity review for azelaic acid 15% gel for inflammatory papules and pustules associated with mild-to-moderate papulopustular rosacea, subject to the stated clinical criteria.
No material clinical or coverage changes in this revision.
Azelaic Acid 15% Gel Coverage Criteria
Azelaic acid 15% gel for papulopustular rosacea
Covered when ALL of the following criteria are met:
Rosacea medical-necessity criteria
- Member age: The member is 18 years of age or older.18 years or older
- Clinical indication: The member is using the requested medication for the treatment of inflammatory papules and pustules of mild-to-moderate rosacea (i.e., papulopustular rosacea).Mild-to-moderate papulopustular rosacea with inflammatory papules and pustules
- Prior topical metronidazole therapy:
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.